BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11004581)

  • 1. Comparison of HOCl traps with myeloperoxidase inhibitors in prevention of low density lipoprotein oxidation.
    Jerlich A; Fritz G; Kharrazi H; Hammel M; Tschabuschnig S; Glatter O; Schaur RJ
    Biochim Biophys Acta; 2000 Aug; 1481(1):109-18. PubMed ID: 11004581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human low density lipoprotein as a target of hypochlorite generated by myeloperoxidase.
    Jerlich A; Fabjan JS; Tschabuschnig S; Smirnova AV; Horakova L; Hayn M; Auer H; Guttenberger H; Leis HJ; Tatzber F; Waeg G; Schaur RJ
    Free Radic Biol Med; 1998 May; 24(7-8):1139-48. PubMed ID: 9626568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative reactivity of the myeloperoxidase-derived oxidants HOCl and HOSCN with low-density lipoprotein (LDL): Implications for foam cell formation in atherosclerosis.
    Ismael FO; Proudfoot JM; Brown BE; van Reyk DM; Croft KD; Davies MJ; Hawkins CL
    Arch Biochem Biophys; 2015 May; 573():40-51. PubMed ID: 25795019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation.
    Fu X; Kassim SY; Parks WC; Heinecke JW
    J Biol Chem; 2003 Aug; 278(31):28403-9. PubMed ID: 12759346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitive Effects of Quercetin on Myeloperoxidase-Dependent Hypochlorous Acid Formation and Vascular Endothelial Injury.
    Lu N; Sui Y; Tian R; Peng YY
    J Agric Food Chem; 2018 May; 66(19):4933-4940. PubMed ID: 29708335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypochlorite induces the formation of LDL(-), a potentially atherogenic low density lipoprotein subspecies.
    Fabjan JS; Abuja PM; Schaur RJ; Sevanian A
    FEBS Lett; 2001 Jun; 499(1-2):69-72. PubMed ID: 11418114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of low-density lipoprotein modification by myeloperoxidase-derived hypochlorous and hypobromous acids.
    Carr AC; Decker EA; Park Y; Frei B
    Free Radic Biol Med; 2001 Jul; 31(1):62-72. PubMed ID: 11425491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins.
    Malle E; Waeg G; Schreiber R; Gröne EF; Sattler W; Gröne HJ
    Eur J Biochem; 2000 Jul; 267(14):4495-503. PubMed ID: 10880973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiocyanate catalyzes myeloperoxidase-initiated lipid oxidation in LDL.
    Exner M; Hermann M; Hofbauer R; Hartmann B; Kapiotis S; Gmeiner B
    Free Radic Biol Med; 2004 Jul; 37(2):146-55. PubMed ID: 15203186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction.
    Abdo AI; Rayner BS; van Reyk DM; Hawkins CL
    Redox Biol; 2017 Oct; 13():623-632. PubMed ID: 28818791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Products of the reaction of HOCl with tryptophan protect LDL from atherogenic modification.
    Kapiotis S; Jirovetz L; Hermann M; Laggner H; Exner M; Esterbauer H; Gmeiner BM
    Biochimie; 2006 Jul; 88(7):785-91. PubMed ID: 16488068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salicylate promotes myeloperoxidase-initiated LDL oxidation: antagonization by its metabolite gentisic acid.
    Hermann M; Kapiotis S; Hofbauer R; Seelos C; Held I; Gmeiner B
    Free Radic Biol Med; 1999 May; 26(9-10):1253-60. PubMed ID: 10381197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins.
    Hazell LJ; Davies MJ; Stocker R
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):489-95. PubMed ID: 10215584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypochlorite-modified low-density lipoprotein induces the apoptotic machinery in Jurkat T-cell lines.
    Resch U; Semlitsch M; Hammer A; Susani-Etzerodt H; Walczak H; Sattler W; Malle E
    Biochem Biophys Res Commun; 2011 Jul; 410(4):895-900. PubMed ID: 21708126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective modification of apoB-100 in the oxidation of low density lipoproteins by myeloperoxidase in vitro.
    Yang CY; Gu ZW; Yang M; Lin SN; Garcia-Prats AJ; Rogers LK; Welty SE; Smith CV
    J Lipid Res; 1999 Apr; 40(4):686-98. PubMed ID: 10191293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of intramolecular and intermolecular sulfenamides, sulfinamides, and sulfonamides by hypochlorous acid: a potential pathway for oxidative cross-linking of low-density lipoprotein by myeloperoxidase.
    Fu X; Mueller DM; Heinecke JW
    Biochemistry; 2002 Jan; 41(4):1293-301. PubMed ID: 11802729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis.
    Hazell LJ; Baernthaler G; Stocker R
    Free Radic Biol Med; 2001 Nov; 31(10):1254-62. PubMed ID: 11705704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminobenzoic acid compounds as HOCl traps for activated neutrophils.
    She ZW; Mays DC; Sagone AL; Davis WB
    Free Radic Biol Med; 1997; 22(6):989-98. PubMed ID: 9034238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
    Hazell LJ; Arnold L; Flowers D; Waeg G; Malle E; Stocker R
    J Clin Invest; 1996 Mar; 97(6):1535-44. PubMed ID: 8617887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorhexidine prevents hypochlorous acid-induced inactivation of alpha1-antitrypsin.
    Montecucco F; Bertolotto M; Ottonello L; Pende A; Dapino P; Quercioli A; Mach F; Dallegri F
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):e72-7. PubMed ID: 19671069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.